Improved survival in liver transplant patients receiving prolonged-release tacrolimus-based immunosuppression in the European Liver Transplant Registry (ELTR): an extension study.
Fiche publication
Date publication
mai 2019
Journal
Transplantation
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BACHELLIER Philippe, Pr HEYD Bruno
Tous les auteurs :
Adam R, Karam V, Cailliez V, Trunečka P, Samuel D, Tisone G, Němec P, Soubrane O, Schneeberger S, Gridelli B, Bechstein WO, Risaliti A, Line PD, Vivarelli M, Rossi M, Pirenne J, Klempnauer JL, Rummo A, Di Benedetto F, Zieniewicz K, Troisi R, Paul A, Vali T, Kollmar O, Boudjema K, Hoti E, Colledan M, Pratschke J, Lang H, Popescu I, Ericzon BG, Strupas K, De Simone P, Kochs E, Heyd B, Gugenheim J, Pinna AD, Bennet W, Kazimi M, Bachellier P, Wigmore SJ, Rasmussen A, Clavien PA, Hidalgo E, O'Grady JG, Zamboni F, Kilic M, Duvoux C,
Lien Pubmed
Résumé
We compare, through the European Liver Transplant Registry, long-term liver transplantation outcomes with prolonged-release tacrolimus (PR-T) versus immediate-release-tacrolimus (IR-T)-based immunosuppression. This retrospective analysis comprises up to 8-year data collected 2008-2016, in an extension of our previously-published study.
Référence
Transplantation. 2019 May 7;: